FDA closer to gaining added funding; is it enough?
This article was originally published in Scrip
Executive Summary
Under a fiscal year 2016 spending bill that easily passed the House Appropriations Committee on 8 July in a voice vote, the FDA would get an additional $30m in discretionary spending and almost $76m in added user fees – or about $106m total – over the agency's current appropriated funding.